Reply to: "Hyperhomocysteinemia predicts liver-related clinical outcomes in the general population"

Affiliations

¹ Laboratory of Hormonal Regulation, Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, 169857, Singapore. Electronic address: madhulika.tripathi@duke-nus.edu.sg.
² Laboratory of Hormonal Regulation, Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, 169857, Singapore.
³ Laboratory of Hormonal Regulation, Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, 169857, Singapore; Duke Molecular Physiology Institute, Duke University School of Medicine, 300 N Duke St, Durham, NC 27701, USA; Endocrinology, Diabetes, and Metabolism Division, Duke University School of Medicine, 300 N Duke St, Durham, NC 27701, USA. Electronic address: paul.yen@duke-nus.edu.sg.

Comment

Madhulika Tripathi et al. J Hepatol. 2023 May.

. 2023 May;78(5):e174-e175.

doi: 10.1016/j.jhep.2023.01.023. Epub 2023 Feb 1.

¹ Laboratory of Hormonal Regulation, Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, 169857, Singapore. Electronic address: madhulika.tripathi@duke-nus.edu.sg.
² Laboratory of Hormonal Regulation, Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, 169857, Singapore.
³ Laboratory of Hormonal Regulation, Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, 169857, Singapore; Duke Molecular Physiology Institute, Duke University School of Medicine, 300 N Duke St, Durham, NC 27701, USA; Endocrinology, Diabetes, and Metabolism Division, Duke University School of Medicine, 300 N Duke St, Durham, NC 27701, USA. Electronic address: paul.yen@duke-nus.edu.sg.

No abstract available

Comment on

Vitamin B₁₂ and folate decrease inflammation and fibrosis in NASH by preventing syntaxin 17 homocysteinylation.
Tripathi M, Singh BK, Zhou J, Tikno K, Widjaja A, Sandireddy R, Arul K, Abdul Ghani SAB, Bee GGB, Wong KA, Pei HJ, Shekeran SG, Sinha RA, Singh MK, Cook SA, Suzuki A, Lim TR, Cheah CC, Wang J, Xiao RP, Zhang X, Chow PKH, Yen PM. Tripathi M, et al. J Hepatol. 2022 Nov;77(5):1246-1255. doi: 10.1016/j.jhep.2022.06.033. Epub 2022 Jul 9. J Hepatol. 2022. PMID: 35820507
Hyperhomocysteinemia predicts liver-related clinical outcomes in the general population.
Åberg F, Jula A, Lundqvist A, Männistö V. Åberg F, et al. J Hepatol. 2023 May;78(5):e172-e174. doi: 10.1016/j.jhep.2022.11.021. Epub 2022 Nov 30. J Hepatol. 2023. PMID: 36460167 No abstract available.